Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort study
Yong-Qin Zeng Jiang Xiao Cui-Lin Li Yu Wang Ling Zhang Xiao-Li Pang Di Wang Juan Du Hong-Xin Zhao
Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort study
Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort study
摘要
关键词
Human immunodeficiency virus(HIV)/Antiretroviral therapy-naive/Bone mineral density/Body mass indexKey words
Human immunodeficiency virus(HIV)/Antiretroviral therapy-naive/Bone mineral density/Body mass index引用本文复制引用
Yong-Qin Zeng,Jiang Xiao,Cui-Lin Li,Yu Wang,Ling Zhang,Xiao-Li Pang,Di Wang,Juan Du,Hong-Xin Zhao..Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults:a Chinese cohort study[J].中华医学杂志（英文版）,2020,133(24):2940-2946,7.基金项目
This study was supported by the grants from the National Key Project"Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis:Popularization and application of diagnosis and treatment of Belt and Road HIV/AIDS with Traditional Chinese Medicine"(No.2018ZX10101001-005-001) （No.2018ZX10101001-005-001）
the National Key Project"The Development of New Pharmaceuticals:the Con-struction of Platform for Clinical Evaluation of New Antiretroviral Therapy-Clinical trial phase Ⅰ-Ⅳ"(No.2017ZX09304027-001-010) （No.2017ZX09304027-001-010）
the Thirteen-fifth Key Project "The Study of Construction of Representative Areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District,Beijing"(No.2018ZX10715-005) （No.2018ZX10715-005）
the National Natural Science Foundation "The Study for Delay and Persistent Poor Immune Reconstitution in HIV/AIDS Patients"(No.81672000) （No.81672000）
Project from Beijing Municipal Committee of Science & Technology "The study of HIV/HBV co-infection"(No.D161100000416004) （No.D161100000416004）
Project for Capital Characteristics "The study for blood concentration of efavirenz influenced by rifampin in HIV/TB co-infected patient"(No.Z171100001017053) （No.Z171100001017053）
The Key Project from Beijing Hospital Authority(No.DFL20191802) （No.DFL20191802）
Major Project of Beijing Municipal Science and Technology Committee(No.D161100000416003). （No.D161100000416003）
